Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2016 Feb 22

PMID 26897357

Citations 7

Authors

Rui Zhang

Wan Yu

Guanyu Liang

Zhanjun Jia

Zhengxin Chen

Lin Zhao

Yongsheng Yuan

Xiaobin Zhou

Daqian Li

Shuying Shen

Ning Liu

Aihua Zhang

Huibo Wang

Gang Wang

Affiliations

Soon will be listed here.

Abstract

Glioblastoma (GBM) is the most common malignant brain tumor with poor prognosis and limited treatment options. Tumor suppressor candidate 1 (TUSC1) was recently identified as a potential tumor suppressor in human cancers. However, the expression and potential function of TUSC1 in GBM remain unclear. Herein, we report that TUSC1 is significantly decreased in GBM tissues and cell lines. Patients with high levels of TUSC1 displayed a significant better survival compared with those with low levels of TUSC1. Functional experiments demonstrated that exogenous expression of TUSC1 inhibited GBM cell proliferation and induced G1 phase arrest by down-regulating CDK4. Moreover, overexpression of TUSC1 retarded tumor growth in vivo. Together, our findings revealed that TUSC1 might be a crucial tumor suppressor gene and a novel therapeutic target for GBM.

Citing Articles

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids.

Duran A, Priestman D, Heras M, Rebolledo-Jaramillo B, Olguin V, Calderon J Int J Mol Sci. 2023; 24(5).

PMID: 36902345 PMC: 10002577. DOI: 10.3390/ijms24054915.

miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis.

Ji L, Wei M, Liu Y, Di Z, Li S Oncol Rep. 2021; 46(6).

PMID: 34664678 PMC: 8548781. DOI: 10.3892/or.2021.8206.

Ribosome-Induced Cellular Multipotency, an Emerging Avenue in Cell Fate Reversal.

Istiaq A, Ohta K Cells. 2021; 10(9).

PMID: 34571922 PMC: 8469204. DOI: 10.3390/cells10092276.

Zheng Z, Zhang L, Tu Z, Deng Y, Yin X Biosci Rep. 2021; 41(3).

PMID: 33682883 PMC: 7982771. DOI: 10.1042/BSR20203812.

Frequent homozygous deletions of the CDKN2A locus in somatic cancer tissues.

Hamid A, Petreaca B, Petreaca R Mutat Res. 2019; 815:30-40.

PMID: 31096160 PMC: 8026102. DOI: 10.1016/j.mrfmmm.2019.04.002.

References

Shan Z, Parker T, Wiest J . Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene. 2004; 23(39):6612-20. PMC: 3449089. DOI: 10.1038/sj.onc.1207857. View

Zhang R, Luo H, Wang S, Chen Z, Hua L, Wang H . MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neurooncol. 2014; 121(1):63-72. DOI: 10.1007/s11060-014-1607-y. View

Park D, Sathornsumetee S, Rich J . Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol. 2010; 7(2):75-7. DOI: 10.1038/nrclinonc.2009.221. View

Zhang R, Luo H, Wang S, Chen W, Chen Z, Wang H . MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1. Neuro Oncol. 2014; 16(11):1510-22. PMC: 4201073. DOI: 10.1093/neuonc/nou111. View

Massague J . G1 cell-cycle control and cancer. Nature. 2004; 432(7015):298-306. DOI: 10.1038/nature03094. View

Kanda M, Shimizu D, Nomoto S, Hibino S, Oya H, Takami H . Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer. J Surg Oncol. 2014; 110(2):136-44. DOI: 10.1002/jso.23614. View

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S . Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Oncol Rep. 2013; 31(3):1305-13. DOI: 10.3892/or.2013.2939. View

Malumbres M, Barbacid M . Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009; 9(3):153-66. DOI: 10.1038/nrc2602. View

10.

Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest J . TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One. 2013; 8(6):e66114. PMC: 3679066. DOI: 10.1371/journal.pone.0066114. View

11.

Meyer M . Malignant gliomas in adults. N Engl J Med. 2008; 359(17):1850. DOI: 10.1056/NEJMc086380. View

12.

Lee M, Yang H . Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev. 2003; 22(4):435-49. DOI: 10.1023/a:1023785332315. View